Table 2 Presenting complaints, co-morbidity and therapeutic characteristics of participants

Presenting complaints

 Flank Pain

25

30.5

 Bipedal Swelling

15

18.3

 Headache

8

9.8

 Abdominal Pain

7

8.5

 Abdominal Distension

6

7.3

 Easy Fatigability

5

6.1

 Dizziness

4

4.9

 Breathlessness

2

2.4

 Early Morning Facial Puffiness

2

2.4

 General Body Weakness

2

2.4

 Vomiting

2

2.4

 Hematuria

2

2.4

 Palpitation

1

1.2

 Polyuria

1

1.2

Co-morbid at the time of presentation

 No co-morbidity

33

40.2

 Hypertension

41

50.0

 Hypertension with diabetes

7

8.5

 Prostatic Hypertrophy

1

1.2

Therapeutic characteristics at the time of presentation

 Irbesartan/Lisinopril

60

73.2

 NifecardXL

43

52.4

 Gliclazide

22

26.8

 CaCO₃

21

25.6

 Fersolate

20

24.4

 Lasix

20

24.4

 Hydralazine

18

22.0

 Folic acid

15

18.3

 EPO

12

14.6

 Methyldopa

11

13.4

 Statin

10

12.2

 NaHCO₃

10

12.2

 Bisoprolol

7

8.5

 Aspirin

3

3.7

 Metformin

3

3.7

 Ranitidine

1

1.2